Developing breakthrough therapies involves significant time, money, and uncertainty, and requires strong evidence-generation to prove value. Real-world data (RWD) from EHRs can help pharmaceutical and medical device companies inform development strategy and alleviate some of these pressures as they seek to bring products to market and prove their efficacy.